Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
- Submitting institution
-
The University of Leeds
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- UOA1-1300
- Type
- D - Journal article
- DOI
-
10.1016/s0140-6736(15)60027-7
- Title of journal
- The Lancet
- Article number
- -
- First page
- 1873
- Volume
- 385
- Issue
- 9980
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- April
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
20
- Research group(s)
-
-
- Citation count
- 240
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Contribution A: Contribution to the conception and design of the study,Contribution to the organisation of the conduct of the study,Contribution to carrying out the study,Contribution to analysis and interpretation of the study data
Contribution B: The author helped draft the output
- Non-English
- No
- English abstract
- -